BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 30766537)

  • 1. Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease.
    Beck DB; Aksentijevich I
    Front Immunol; 2019; 10():101. PubMed ID: 30766537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.
    Manthiram K; Zhou Q; Aksentijevich I; Kastner DL
    Nat Immunol; 2017 Jul; 18(8):832-842. PubMed ID: 28722725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New players driving inflammation in monogenic autoinflammatory diseases.
    Martinon F; Aksentijevich I
    Nat Rev Rheumatol; 2015 Jan; 11(1):11-20. PubMed ID: 25247411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monogenic autoinflammatory disorders: beyond the periodic fever.
    Moghaddas F
    Intern Med J; 2020 Feb; 50(2):151-164. PubMed ID: 31260149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.
    de Jesus AA; Canna SW; Liu Y; Goldbach-Mansky R
    Annu Rev Immunol; 2015; 33():823-74. PubMed ID: 25706096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical landmarks in systemic autoinflammatory diseases.
    Cantarini L; Rigante D; Brizi MG; Lucherini OM; Sebastiani GD; Vitale A; Gianneramo V; Galeazzi M
    Ann Med; 2012 Nov; 44(7):664-73. PubMed ID: 21972825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New autoinflammatory diseases.
    Poli MC
    Curr Opin Pediatr; 2018 Dec; 30(6):837-847. PubMed ID: 30320618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.
    Jamilloux Y; Belot A; Magnotti F; Benezech S; Gerfaud-Valentin M; Bourdonnay E; Walzer T; Sève P; Henry T
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):454-479. PubMed ID: 28578473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the genetically complex autoinflammatory diseases.
    Ombrello MJ
    Semin Immunopathol; 2015 Jul; 37(4):403-6. PubMed ID: 26077134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Inflammatory Response in Autoinflammatory Disorders: Autonomous and Hyperinflammatory States.
    Gül A
    Front Immunol; 2018; 9():2422. PubMed ID: 30386349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actin Remodeling Defects Leading to Autoinflammation and Immune Dysregulation.
    Papa R; Penco F; Volpi S; Gattorno M
    Front Immunol; 2020; 11():604206. PubMed ID: 33488606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoinflammation: Interferonopathies and Other Autoinflammatory Diseases.
    Savic S; Coe J; Laws P
    J Invest Dermatol; 2022 Mar; 142(3 Pt B):781-792. PubMed ID: 34887082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.
    Aksentijevich I; Schnappauf O
    Nat Rev Rheumatol; 2021 Jul; 17(7):405-425. PubMed ID: 34035534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment.
    Havnaer A; Han G
    Am J Clin Dermatol; 2019 Aug; 20(4):539-564. PubMed ID: 30997665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No shortcuts: new findings reinforce why nuance is the rule in genetic autoinflammatory syndromes.
    Tsoukas P; Canna SW
    Curr Opin Rheumatol; 2017 Sep; 29(5):506-515. PubMed ID: 28604422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary Autoinflammatory Disorders: Recognition and Treatment.
    Broderick L
    Immunol Allergy Clin North Am; 2019 Feb; 39(1):13-29. PubMed ID: 30466770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases.
    Lucherini OM; Rigante D; Sota J; Fabiani C; Obici L; Cattalini M; Gattorno M; Cantarini L
    Clin Exp Rheumatol; 2018; 36 Suppl 110(1):3-9. PubMed ID: 29742053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving towards a systems-based classification of innate immune-mediated diseases.
    Savic S; Caseley EA; McDermott MF
    Nat Rev Rheumatol; 2020 Apr; 16(4):222-237. PubMed ID: 32107482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burgeoning field of innate immune-mediated disease and autoinflammation.
    Peckham D; Scambler T; Savic S; McDermott MF
    J Pathol; 2017 Jan; 241(2):123-139. PubMed ID: 27682255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases.
    Szekanecz Z; McInnes IB; Schett G; Szamosi S; Benkő S; Szűcs G
    Nat Rev Rheumatol; 2021 Oct; 17(10):585-595. PubMed ID: 34341562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.